Category: Diagnostics
Global Diagnostics
-
Medical Connectors
... CAGR of 5.5% over the analysis period 2024-2030. Hospital & Clinics End-Use, one of the segments analyzed in the report, is expected to record a 5.3% CAGR and reach US$2.7 Billion by the end of ... Read More
-
STD Testing
... CAGR of 5.2% over the analysis period 2024-2030. Chlamydia Testing, one of the segments analyzed in the report, is expected to record a 5.0% CAGR and reach US$40.6 Billion by the end of the analysis ... Read More
-
Endobronchial Ultrasound Biopsy Devices
... 2030, growing at a CAGR of 4.3% over the analysis period 2024-2030. Transbronchial Aspiration Needles, one of the segments analyzed in the report, is expected to record a 4.8% CAGR and reach US$334.8 Million by ... Read More
-
Thyroid Function Tests
... at a CAGR of 4.0% over the analysis period 2024-2030. TSH Tests, one of the segments analyzed in the report, is expected to record a 4.0% CAGR and reach US$1.2 Billion by the end of ... Read More
-
Refurbished Medical Imaging Equipment
... 2030, growing at a CAGR of 10.6% over the analysis period 2024-2030. CT Scanners, one of the segments analyzed in the report, is expected to record a 9.3% CAGR and reach US$2.9 Billion by the ... Read More
-
Veterinary Hematology Analyzers
... at a CAGR of 5.3% over the analysis period 2024-2030. Table Top Analyzers, one of the segments analyzed in the report, is expected to record a 5.3% CAGR and reach US$1.2 Billion by the end ... Read More
-
Fluoroscopy and Mobile C-Arms
... 2030, growing at a CAGR of 3.8% over the analysis period 2024-2030. Fluoroscopy, one of the segments analyzed in the report, is expected to record a 3.3% CAGR and reach US$2.2 Billion by the end ... Read More
-
Western Blotting
... CAGR of 5.3% over the analysis period 2024-2030. Western Blotting Consumables, one of the segments analyzed in the report, is expected to record a 5.4% CAGR and reach US$1.1 Billion by the end of the ... Read More
-
X-Ray Tubes
... CAGR of 3.9% over the analysis period 2024-2030. Healthcare End-Use, one of the segments analyzed in the report, is expected to record a 4.3% CAGR and reach US$3.0 Billion by the end of the analysis ... Read More
-
Flat Panel X-Ray Detectors
... 2030, growing at a CAGR of 4.6% over the analysis period 2024-2030. Manufacturing Application, one of the segments analyzed in the report, is expected to record a 4.1% CAGR and reach US$741.3 Million by the ... Read More
-
Medical Imaging Information Systems
... 2030, growing at a CAGR of 4.0% over the analysis period 2024-2030. Computed Tomography Modality, one of the segments analyzed in the report, is expected to record a 5.2% CAGR and reach US$390.1 Million by ... Read More
-
Vendor Neutral Archives
... at a CAGR of 6.5% over the analysis period 2024-2030. On-Premises Delivery, one of the segments analyzed in the report, is expected to record a 5.8% CAGR and reach US$552.5 Million by the end of ... Read More
-
Chlamydia Infection Diagnostics and Therapeutics
... Billion by 2030, growing at a CAGR of 4.8% over the analysis period 2024-2030. Chlamydia Infection Diagnostics, one of the segments analyzed in the report, is expected to record a 5.1% CAGR and reach US$1.6 ... Read More
-
Advanced Visualization Market by Type (Enterprise, Standalone), Modality (MRI, CT, PET, Ultrasound, Radiotherapy, Nuclear Medicine), Application (Radiology, Oncology, Neuro), End User (Hospital, ASC, Diagnostic Center) & Region - Global Forecast to 2029
... as a result of the increasing investments & fundings by public-private organizations, surging demand for technologically advanced visualization solutions for various applications across the industry, such as, cardiology, radiology, neurology, oncology, among others. Moreover, the ... Read More
-
Point of Care (POC) Molecular Diagnostics
... reach US$8.8 Billion by 2030, growing at a CAGR of 12.9% over the analysis period 2024-2030. Infectious Diseases Application, one of the segments analyzed in the report, is expected to record a 12.9% CAGR and ... Read More
-
Automated and Rapid Microbiological Tests
... Billion by 2030, growing at a CAGR of 6.7% over the analysis period 2024-2030. GC/CRT (Clinical) Application, one of the segments analyzed in the report, is expected to record a 8.0% CAGR and reach US$1.3 ... Read More
-
Intravascular Ultrasound (IVUS)
... at a CAGR of 7.7% over the analysis period 2024-2030. IVUS Catheters, one of the segments analyzed in the report, is expected to record a 8.4% CAGR and reach US$659.0 Million by the end of ... Read More
-
Tissue Diagnostics
... CAGR of 6.6% over the analysis period 2024-2030. Tissue Diagnostics Consumables, one of the segments analyzed in the report, is expected to record a 6.8% CAGR and reach US$8.4 Billion by the end of the ... Read More
-
Cardiology IT Workflow Solutions
... 2030, growing at a CAGR of 8.0% over the analysis period 2024-2030. Cloud Deployment, one of the segments analyzed in the report, is expected to record a 9.0% CAGR and reach US$1.1 Billion by the ... Read More
-
Automated Blood Tube Labelers and Specimen Transport Boxes
... 2024, is expected to reach US$518.8 Million by 2030, growing at a CAGR of 7.5% over the analysis period 2024-2030. Hospitals End-Use, one of the segments analyzed in the report, is expected to record a ... Read More
-
3D Medical Imaging
... at a CAGR of 6.1% over the analysis period 2024-2030. CT Devices, one of the segments analyzed in the report, is expected to record a 6.6% CAGR and reach US$8.9 Billion by the end of ... Read More
-
Aptamers
... 15.7% over the analysis period 2024-2030. DNA Aptamers, one of the segments analyzed in the report, is expected to record a 15.7% CAGR and reach US$227.5 Million by the end of the analysis period. Growth ... Read More
-
Automated Liquid Handling Systems
... 2030, growing at a CAGR of 10.8% over the analysis period 2024-2030. Automated Liquid Handling Workstations, one of the segments analyzed in the report, is expected to record a 11.6% CAGR and reach US$1.6 Billion ... Read More
-
Coagulation Testing
... CAGR of 4.8% over the analysis period 2024-2030. Coagulation Testing Consumables, one of the segments analyzed in the report, is expected to record a 5.1% CAGR and reach US$3.7 Billion by the end of the ... Read More
-
C-Reactive Protein Testing
... at a CAGR of 1.7% over the analysis period 2024-2030. Cardiovascular Diseases, one of the segments analyzed in the report, is expected to record a 2.6% CAGR and reach US$1.0 Billion by the end of ... Read More